These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32634344)

  • 1. Quantification of the relationship between pyoderma gangrenosum and Crohn's disease: a population-based case-control study.
    Kridin K; Damiani G; Ludwig RJ; Tzur-Bitan D; Cohen AD
    Scand J Gastroenterol; 2020 Jul; 55(7):814-818. PubMed ID: 32634344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis and pyoderma gangrenosum: a population-based case-control study.
    Kridin K; Damiani G; Cohen AD
    Clin Rheumatol; 2021 Feb; 40(2):521-528. PubMed ID: 32613390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the Odds of Ulcerative Colitis-Associated Pyoderma Gangrenosum: A Population-Based Case-Control Study.
    Kridin K; Damiani G; Ludwig RJ; Tzur Bitan D; Cohen AD
    Dermatology; 2021; 237(3):323-329. PubMed ID: 33647909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    States V; O'Brien S; Rai JP; Roberts HL; Paas M; Feagins K; Pierce EJ; Baumgartner RN; Galandiuk S
    Dig Dis Sci; 2020 Sep; 65(9):2675-2685. PubMed ID: 31925675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall and subgroup prevalence of pyoderma gangrenosum among patients with hidradenitis suppurativa: A population-based analysis in the United States.
    Tannenbaum R; Strunk A; Garg A
    J Am Acad Dermatol; 2019 Jun; 80(6):1533-1537. PubMed ID: 30738122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic renal comorbidities in pyoderma gangrenosum: a retrospective cohort study.
    Kridin K; Solomon A; Britva RL; Bitan DT; Cohen AD
    Immunol Res; 2021 Jun; 69(3):249-254. PubMed ID: 33890227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short article: Crohn's disease and pemphigus: is there an association?: a population-based study.
    Kridin K; Comaneshter D; Cohen AD
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):727-729. PubMed ID: 29688902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services' Adult Hospital 1998-2009.
    Polcz M; Gu J; Florin T
    J Crohns Colitis; 2011 Apr; 5(2):148-51. PubMed ID: 21453884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is pyoderma gangrenosum associated with solid malignancies? Insights from a population-based cohort study.
    Kridin K; Laufer Britva R; Tzur Bitan D; Damiani G; Cohen AD
    Australas J Dermatol; 2021 Aug; 62(3):336-341. PubMed ID: 34076886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease.
    Freeman HJ
    Can J Gastroenterol; 2005 Oct; 19(10):603-6. PubMed ID: 16247522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scrotal pyoderma gangrenosum associated with Crohn's disease.
    Ho SA; Tan WP; Tan AW; Wong SN; Chua SH
    Singapore Med J; 2009 Dec; 50(12):e397-400. PubMed ID: 20087538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Gout Associated with Pyoderma Gangrenosum? A Population-Based Case-Control Study.
    Kridin K; Ludwig RJ; Tzur Bitan D; Kridin M; Damiani G; Cohen AD
    J Clin Med; 2020 May; 9(6):. PubMed ID: 32481527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From guts to skin; unmasking risk factors of pyoderma gangrenosum among Crohn's disease patients.
    Schroeder C; Verma R; Liu L; Sakhthivel H; Min Tun K; Ramphul K; Singh Dhindsa B
    Arch Dermatol Res; 2024 Jul; 316(7):450. PubMed ID: 38967803
    [No Abstract]   [Full Text] [Related]  

  • 15. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid-resistant pyoderma gangrenosum associated with Crohn's disease: rapid cure with infliximab.
    Grange F; Djilali-Bouzina F; Weiss AM; Polette A; Guillaume JC
    Dermatology; 2002; 205(3):278-80. PubMed ID: 12399677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
    Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
    Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
    Menachem Y; Gotsman I
    Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pyoderma gangrenosum with infliximab in Crohn's disease.
    Sapienza MS; Cohen S; Dimarino AJ
    Dig Dis Sci; 2004 Sep; 49(9):1454-7. PubMed ID: 15481318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.